ASP-7962

N/A

Report date: 2022/07/19 20:00:45
NME

Base Information

Drug NameASP-7962
Drug Alias NameASP-7962
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNerve growth factor receptor Trk-A antagonists
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsBack PainOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumHungary +[6] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstellas Pharma Europe Bv
Active IndicationsN/A
Inactive IndicationsBack PainOsteoarthritis, Knee

Other Information

ATC CodeN/A
Related LinksN/A